Bi-Specific Fusion Proteins
US-2024101713-A1 · Mar 28, 2024 · US
This page is not indexed by search engines while we improve data quality.
Nielsen Ulrik patents
Nielsen Ulrik is listed as an inventor on 23 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Nielsen Ulrik |
| Total patents | 23 |
| First publication | Feb 24, 2015 |
| Latest publication | Mar 28, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Nanoparticle systems to stimulate and maintain immune system responsiveness at treatment sites
US-2023331804-A1 · Oct 19, 2023 · US
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
US-10072299-B2 · Sep 11, 2018 · US
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
US-9902999-B2 · Feb 27, 2018 · US
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
US-9885087-B2 · Feb 6, 2018 · US
Monoclonal and oligoclonal anti-egfr antibodies for use in the treatment of tumors expressing predominantly high affinity egfr ligands or tumors expressing predominantly low affinity egfr ligands
US-2017356049-A1 · Dec 14, 2017 · US
Bi-Specific Fusion Proteins
US-2017335015-A1 · Nov 23, 2017 · US
Methods, systems and products for predicting response of tumor cells to a therapeutic agent and treating a patient according to the predicted response
US-2017307631-A1 · Oct 26, 2017 · US
Method of treating myocardial infarction by administering a bi-specific fusion protein
US-9718892-B2 · Aug 1, 2017 · US
Bispecific binding agents targeting the igf-1r and erbb3 pathways and uses thereof
US-2017210809-A1 · Jul 27, 2017 · US
Recent patents
Latest publications not already listed above.
Antibodies against the ectodomain of erbb3 and uses thereof
US-2017073427-A1 · Mar 16, 2017 · US
Antibodies against the ectodomain of ERBB3 and uses thereof
US-9487588-B2 · Nov 8, 2016 · US
Bi-Specific Fusion Proteins
US-2016168269-A1 · Jun 16, 2016 · US
Monoclonal and oligoclonal anti-egfr antibodies for use in the treatment of tumors expressing predominantly high affinity egfr ligands or tumors expressing predominantly low affinity egfr ligands
US-2016083800-A1 · Mar 24, 2016 · US
Bi-specific fusion proteins
US-9238080-B2 · Jan 19, 2016 · US
Antibodies against epidermal growth factor receptor (egfr) and uses thereof
US-2016002339-A1 · Jan 7, 2016 · US
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
US-9226964-B2 · Jan 5, 2016 · US
Antibodies against epidermal growth factor receptor (egfr) and uses thereof
US-2015376284-A1 · Dec 31, 2015 · US
Antibodies against epidermal growth factor receptor (egfr) and uses thereof
US-2015368347-A1 · Dec 24, 2015 · US
Antibodies against epidermal growth factor receptor (egfr) and uses thereof
US-2015368346-A1 · Dec 24, 2015 · US
Antibodies against epidermal growth factor receptor (egfr) and uses thereof
US-2015368361-A1 · Dec 24, 2015 · US
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
US-9044460-B2 · Jun 2, 2015 · US
Antibodies against ERBB3 and uses thereof
US-8961966-B2 · Feb 24, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Merrimack Pharmaceuticals Inc | 21 |
| Adimab Llc | 4 |
| Nielsen Ulrik | 3 |
| Feldhaus Michael | 2 |
| Schoeberl Birgit | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/76 | 21 |
| A61P43/00 | 20 |
| A61P35/00 | 18 |
| C07K16/2863 | 17 |
| A61P11/00 | 17 |